Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
Neurology|June 15, 2007
Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the familiesA J van der Kooi, W S Frankhuizen, P G Barth, et al.
Journal of Neuroimmunology|July 23, 2008
The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patientsM J Titulaer, P W Wirtz, J B M Kuks, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 14, 2013
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapyJ C van den Bergen, S M Schade van Westrum, L Dekker, et al.
Neurology|September 1, 1996
Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth diseaseA A Gabreëls-Festen, J E Hoogendijk, P H Meijerink, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2026
Pyocyanin produced by Pseudomonas aeruginosa creates legacy effects that promote antibiotic resistance evolution in enterococciM G J de Vos, V Jansen, O El Bouhlali, et al.
Seminars in Arthritis and Rheumatism|December 23, 2023
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working GroupD Saygin, D DiRenzo, J Raaphorst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2002
Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndromeP W Wirtz, M Sotodeh, M Nijnuis, et al.
Neurology|May 16, 2007
Phenotype of Charcot-Marie-Tooth disease Type 2H M E Bienfait, F Baas, J H T M Koelman, et al.
International Journal of Cancer|October 12, 2024
Diagnostic performance of tomosynthesis plus synthetic mammography versus full-field digital mammography with or without tomosynthesis in breast cancer screening: A systematic review and meta-analysisWasim Hamad, Michael J Michell, Jonathan P Myles, et al.
Drug Delivery|June 13, 2018
Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritisA R Tellegen, I Rudnik-Jansen, B Pouran, et al.
Pageof 25